# Efficacy and Safety of Metoprolol Tartrate Tablets Combined With Chinese Traditional Medicine on Premature Ventricular Complex.

Study · id `cardio:ct-nct05008250` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05008250](<https://clinicaltrials.gov/study/NCT05008250>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05008250

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 584 participants.

## Technical summary

Registry record NCT05008250. Randomized; double masking; primary purpose treatment. Start 2014-01 (actual); primary completion 2015-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 584 participants (enrolled count; ClinicalTrials.gov record NCT05008250, source copy `cardio:ctgov-nct05008250-2021-08-17`, retrieved 2026-10-26)
- Started: 2014-01 (actual) (ClinicalTrials.gov record NCT05008250, source copy `cardio:ctgov-nct05008250-2021-08-17`, retrieved 2026-10-26)
- Primary completion: 2015-08 (actual) (ClinicalTrials.gov record NCT05008250, source copy `cardio:ctgov-nct05008250-2021-08-17`, retrieved 2026-10-26)
- Completion: 2016-08 (actual) (ClinicalTrials.gov record NCT05008250, source copy `cardio:ctgov-nct05008250-2021-08-17`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05008250-2021-08-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety of Metoprolol Tartrate Tablets Combined With Chinese Traditional Medicine on Premature Ventricular Complex.
- Condition: Premature Ventricular Contraction
- Intervention (Drug): Tongmai Yangxin Pill (TMYXP)
- Intervention (Drug): metoprolol tartrate
- Intervention (Drug): placebo
- Lead sponsor: Xuanwu Hospital, Beijing
- Lead sponsor class: OTHER
- Collaborator: Tianjin Lerentang factory
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Premature heartbeats (`cardio:premature-heartbeats`)
- Registry lists this organization as the lead sponsor: Xuanwu Hospital, Beijing (`cardio:org-xuanwu-hospital-beijing`)

## Provenance

Content hash: de0498800c6991df5b4ccd48a8634328218426837446bb20c5f4ea0add26be14
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
